Stay updated on SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.

Latest updates to the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThe revision tag on the page was updated from v3.6.2 to v3.6.3. This appears to be a small metadata update and does not alter the trial information presented.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This change does not modify study details or other page content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a recruitment notice indicating no longer looking for participants and introduced new participant guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated label for Intervention/Treatment. The page revision metadata now shows Revision: v3.6.0 (replacing v3.5.5).SummaryDifference0.3%

- Check35 days agoChange DetectedThe page now shows revision v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the page metadata or content.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now shows Revision: v3.5.4, indicating a minor update to the page's revision history.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page’s footer/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend or display version change rather than a change to the clinical study details.SummaryDifference0.0%

Stay in the know with updates to SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.